These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 10845612

  • 21. Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells.
    Hangai M, Murata T, Miyawaki N, Spee C, Lim JI, He S, Hinton DR, Ryan SJ.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1617-25. PubMed ID: 11381069
    [Abstract] [Full Text] [Related]

  • 22. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
    Mason JC, Lidington EA, Yarwood H, Lublin DM, Haskard DO.
    Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
    [Abstract] [Full Text] [Related]

  • 23. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
    Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P, Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ.
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
    [Abstract] [Full Text] [Related]

  • 24. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
    Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, Uemura A, Honda Y.
    Proc Natl Acad Sci U S A; 2002 Jan 08; 99(1):383-8. PubMed ID: 11756651
    [Abstract] [Full Text] [Related]

  • 25. Insulin-induced vascular endothelial growth factor expression in retina.
    Lu M, Amano S, Miyamoto K, Garland R, Keough K, Qin W, Adamis AP.
    Invest Ophthalmol Vis Sci; 1999 Dec 08; 40(13):3281-6. PubMed ID: 10586954
    [Abstract] [Full Text] [Related]

  • 26. Effects of VEGFR-1, VEGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells.
    Spoerri PE, Afzal A, Li Calzi S, Shaw LC, Cai J, Pan H, Boulton M, Grant MB.
    Mol Vis; 2006 Jan 12; 12():32-42. PubMed ID: 16446700
    [Abstract] [Full Text] [Related]

  • 27. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
    Brankin B, Campbell M, Canning P, Gardiner TA, Stitt AW.
    Exp Eye Res; 2005 Jul 12; 81(1):22-31. PubMed ID: 15978251
    [Abstract] [Full Text] [Related]

  • 28. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A.
    Hofman P, Blaauwgeers HG, Tolentino MJ, Adamis AP, Nunes Cardozo BJ, Vrensen GF, Schlingemann RO.
    Curr Eye Res; 2000 Aug 12; 21(2):637-45. PubMed ID: 11148600
    [Abstract] [Full Text] [Related]

  • 29. Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway.
    Simorre-Pinatel V, Guerrin M, Chollet P, Penary M, Clamens S, Malecaze F, Plouet J.
    Invest Ophthalmol Vis Sci; 1994 Aug 12; 35(9):3393-400. PubMed ID: 8056513
    [Abstract] [Full Text] [Related]

  • 30. Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation.
    DeBosch BJ, Baur E, Deo BK, Hiraoka M, Kumagai AK.
    J Neurochem; 2001 May 12; 77(4):1157-67. PubMed ID: 11359881
    [Abstract] [Full Text] [Related]

  • 31. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 12; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

  • 32. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells.
    Koyama S, Takagi H, Otani A, Suzuma K, Nishimura K, Honda Y.
    Br J Pharmacol; 1999 May 12; 127(2):537-45. PubMed ID: 10385256
    [Abstract] [Full Text] [Related]

  • 33. Up-regulation of vascular endothelial growth factor and down-regulation of pigment epithelium-derived factor messenger ribonucleic acid levels in leptin-exposed cultured retinal pericytes.
    Yamagishi S, Inagaki Y, Amano S, Okamoto T, Takeuchi M.
    Int J Tissue React; 2002 May 12; 24(4):137-42. PubMed ID: 12779248
    [Abstract] [Full Text] [Related]

  • 34. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK, Suzuma K, King AL, Aiello LP, King GL.
    Invest Ophthalmol Vis Sci; 2002 Feb 12; 43(2):503-9. PubMed ID: 11818397
    [Abstract] [Full Text] [Related]

  • 35. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
    Campbell M, Collery R, McEvoy A, Gardiner TA, Stitt AW, Brankin B.
    Curr Eye Res; 2006 Dec 12; 31(12):1033-45. PubMed ID: 17169842
    [Abstract] [Full Text] [Related]

  • 36. Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor.
    Calnek DS, Grinnell BW.
    Exp Cell Res; 1998 Jan 10; 238(1):294-8. PubMed ID: 9457083
    [Abstract] [Full Text] [Related]

  • 37. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
    Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP.
    Invest Ophthalmol Vis Sci; 2001 Sep 10; 42(10):2408-13. PubMed ID: 11527957
    [Abstract] [Full Text] [Related]

  • 38. Selective killing of RPE with a vascular endothelial growth factor chimeric toxin.
    Hoffmann S, Masood R, Zhang Y, He S, Ryan SJ, Gill P, Hinton DR.
    Invest Ophthalmol Vis Sci; 2000 Jul 10; 41(8):2389-93. PubMed ID: 10892888
    [Abstract] [Full Text] [Related]

  • 39. Regulation of glucose transporter 1 (GLUT1) gene expression by epidermal growth factor in bovine corneal endothelial cells.
    Ishida K, Yamashita H, Katagiri H, Oka Y.
    Jpn J Ophthalmol; 1995 Jul 10; 39(3):225-32. PubMed ID: 8577072
    [Abstract] [Full Text] [Related]

  • 40. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R, Gingras D, Kruger EA, Lamy S, Sirois P, Simard B, Sirois MG, Tranqui L, Baffert F, Beaulieu E, Dimitriadou V, Pépin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E.
    Clin Cancer Res; 2002 Apr 10; 8(4):1242-50. PubMed ID: 11948139
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.